195 related articles for article (PubMed ID: 12036694)
1. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration.
Jonas JB
Am J Ophthalmol; 2002 Jun; 133(6):857; author reply 857-9. PubMed ID: 12036694
[No Abstract] [Full Text] [Related]
2. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in best disease.
Andrade RE; Farah ME; Costa RA
Am J Ophthalmol; 2003 Dec; 136(6):1179-81. PubMed ID: 14644242
[TBL] [Abstract][Full Text] [Related]
4. Treatment of juxtafoveal and extrafoveal choroidal neovascularization in the era of photodynamic therapy with verteporfin.
Jampol LM; Scott L
Am J Ophthalmol; 2002 Jul; 134(1):99-101. PubMed ID: 12095815
[No Abstract] [Full Text] [Related]
5. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
Bressler NM;
Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
[TBL] [Abstract][Full Text] [Related]
6. Japanese age-related macular degeneration trial: 1-year results of photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
Japanese Age-Related Macular Degeneration Tial (JAT) Study Group
Am J Ophthalmol; 2003 Dec; 136(6):1049-61. PubMed ID: 14644215
[TBL] [Abstract][Full Text] [Related]
7. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2.
Bressler NM
Am J Ophthalmol; 2002 Jan; 133(1):168-9. PubMed ID: 11755871
[No Abstract] [Full Text] [Related]
8. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
[TBL] [Abstract][Full Text] [Related]
9. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.
Verteporfin In Photodynamic Therapy Study Group
Am J Ophthalmol; 2001 May; 131(5):541-60. PubMed ID: 11336929
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment--TAP and VIP report No. 2.
Barbazetto I; Burdan A; Bressler NM; Bressler SB; Haynes L; Kapetanios AD; Lukas J; Olsen K; Potter M; Reaves A; Rosenfeld P; Schachat AP; Strong HA; Wenkstern A; ;
Arch Ophthalmol; 2003 Sep; 121(9):1253-68. PubMed ID: 12963608
[TBL] [Abstract][Full Text] [Related]
11. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.
Hariprasad SM; Shah GK
Ophthalmic Surg Lasers Imaging; 2005; 36(3):258-60. PubMed ID: 15957487
[TBL] [Abstract][Full Text] [Related]
12. [Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in central serous chorioretinopathy: case report].
Maia HS; Turchetti R; Zajdenweber M; Brasil OF
Arq Bras Oftalmol; 2005; 68(4):561-4. PubMed ID: 16322848
[TBL] [Abstract][Full Text] [Related]
13. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: 5-year results of two randomized clinical trials with an open-label extension: TAP report no. 8.
Kaiser PK;
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1132-42. PubMed ID: 16538452
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy with verteporfin in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration (AMD): results of the Japanese AMD Trial (JAT) extension.
; Ohji M
Jpn J Ophthalmol; 2008; 52(2):99-107. PubMed ID: 18626732
[TBL] [Abstract][Full Text] [Related]
15. Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization.
Gelisken F; Inhoffen W; Partsch M; Schneider U; Kreissig I
Am J Ophthalmol; 2001 Apr; 131(4):518-20. PubMed ID: 11292425
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography following photodynamic therapy with verteporfin for subfoveal predominantly classic choroidal neovascularization.
Park CH; Smith BT; Oh M; Fekrat S
Ann Ophthalmol (Skokie); 2006; 38(2):121-5. PubMed ID: 17416941
[TBL] [Abstract][Full Text] [Related]
17. Circulatory changes in the choroidal vasculature after verteporfin-based photodynamic therapy for choroidal neovascularization in age-related macular degeneration.
Isola V; Pece A; Brancato R
Retina; 2004 Aug; 24(4):618-20. PubMed ID: 15300088
[No Abstract] [Full Text] [Related]
18. Prognosis for placebo-treated eyes in VIP report 2.
Da Pozzo S; Parodi MB
Am J Ophthalmol; 2002 Feb; 133(2):294-6. PubMed ID: 11812454
[No Abstract] [Full Text] [Related]
19. Short-term reaction of choroidal neovascularization and choriocapillaris to photodynamic therapy in age-related macular degeneration.
Eter N; Vogel A; Inhetvin-Hutter C; Spitznas M
Eur J Ophthalmol; 2003 Oct; 13(8):687-92. PubMed ID: 14620172
[TBL] [Abstract][Full Text] [Related]
20. Verteporfin photodynamic therapy for extrafoveal choroidal neovascularisation secondary to age-related macular degeneration.
Voelker M; Gelisken F; Ziemssen F; Wachtlin J; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1241-6. PubMed ID: 16010552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
